| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023181953 |
| P356 | DOI | 10.1186/1475-2875-6-82 |
| P932 | PMC publication ID | 1920526 |
| P698 | PubMed publication ID | 17598897 |
| P5875 | ResearchGate publication ID | 6238480 |
| P50 | author | Kevin Marsh | Q30102986 |
| David J. Conway | Q30347162 | ||
| P2093 | author name string | Samson M Kinyanjui | |
| David E Lanar | |||
| P2860 | cites work | Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster | Q29614923 |
| Maintenance of serological memory by polyclonal activation of human memory B cells. | Q52008907 | ||
| Immunity to diphtheria and tetanus in England and Wales. | Q52025421 | ||
| Humoral immunity due to long-lived plasma cells. | Q52040025 | ||
| Soluble immune complex triggering of a respiratory burst in macrophages: the role of complex aggregation at the phagocyte surface. | Q53883574 | ||
| Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. | Q54638975 | ||
| The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity | Q78346721 | ||
| A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission | Q34001155 | ||
| Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli | Q34122492 | ||
| Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization | Q34364510 | ||
| Humoral immunity and long-lived plasma cells | Q34712731 | ||
| Metabolic properties of IgG subclasses in man | Q35576283 | ||
| Molecular mechanisms of measles virus persistence | Q36127607 | ||
| Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival | Q36368882 | ||
| Antibody responses to Rhoptry-Associated Protein-1 (RAP-1) of Plasmodium falciparum parasites in humans from areas of different malaria endemicity. | Q36888215 | ||
| Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs | Q37290484 | ||
| High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya | Q39362550 | ||
| Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria | Q39362569 | ||
| A model for sequestration of the transmission stages of Plasmodium falciparum: adhesion of gametocyte-infected erythrocytes to human bone marrow cells. | Q39405774 | ||
| Impairment of the immune response to vaccination after acute malaria | Q39492883 | ||
| Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies | Q39830868 | ||
| Disorders of immunoglobulin metabolism | Q39878222 | ||
| Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived | Q40150215 | ||
| Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea | Q40694087 | ||
| Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1. | Q41923301 | ||
| Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population. | Q45120907 | ||
| Acquired antibody levels to Plasmodium falciparum merozoite surface antigen 1 in residents of a highly endemic area of Papua New Guinea | Q46152931 | ||
| Loss of red blood cell-complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia | Q46732419 | ||
| Persistence of vaccine-induced antibody to measles 26-33 years after vaccination | Q47708271 | ||
| A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. | Q47832886 | ||
| Distribution of immunoglobulin isotypes in the nonspecific B-cell response induced by infection with Plasmodium chabaudi adami and Plasmodium yoelii | Q47925879 | ||
| Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis | Q47932952 | ||
| Long-lived plasma cells: a mechanism for maintaining persistent antibody production | Q47933811 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Kenya | Q114 |
| antibody | Q79460 | ||
| Plasmodium falciparum | Q311383 | ||
| merozoite | Q2296434 | ||
| P304 | page(s) | 82 | |
| P577 | publication date | 2007-06-28 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life | |
| P478 | volume | 6 |
| Q38648457 | A longitudinal cohort study of malaria exposure and changing serostatus in a malaria endemic area of rural Tanzania |
| Q33802641 | A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali |
| Q33380204 | Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum |
| Q33760116 | Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria. |
| Q37641378 | Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection |
| Q37191417 | Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure |
| Q33333604 | Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses |
| Q36917011 | Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission |
| Q47996539 | Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, India |
| Q61805875 | Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure |
| Q35570377 | Assessment of exposure to Plasmodium falciparum transmission in a low endemicity area by using multiplex fluorescent microsphere-based serological assays |
| Q33344450 | Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study |
| Q35965161 | Asymptomatic Multiclonal Plasmodium falciparum Infections Carried Through the Dry Season Predict Protection Against Subsequent Clinical Malaria |
| Q37713335 | B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites |
| Q59349637 | Basics of memory B-cell responses: lessons from and for the real world |
| Q36071335 | Biosignatures of Exposure/Transmission and Immunity |
| Q37247251 | Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria |
| Q34796738 | Changes in B Cell Populations and Merozoite Surface Protein-1-Specific Memory B Cell Responses after Prolonged Absence of Detectable P. falciparum Infection |
| Q59330088 | Characterization of anti-EBA175RIII-V in asymptomatic adults and children living in communities in the Greater Accra Region of Ghana with varying malaria transmission intensities |
| Q28477259 | Clearance of asymptomatic P. falciparum Infections Interacts with the number of clones to predict the risk of subsequent malaria in Kenyan children |
| Q61445471 | Comparative analysis of IgG and IgG subclasses against Plasmodium falciparum MSP-1 in children from five contrasting bioecological zones of Cameroon |
| Q37631228 | Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life |
| Q36418338 | Correlates of HIV and malaria co-infection in Southern India |
| Q39111609 | Cutting Edge: IL-10 Is Essential for the Generation of Germinal Center B Cell Responses and Anti-Plasmodium Humoral Immunity |
| Q41991578 | Declining malaria transmission differentially impacts on the maintenance of humoral immunity to Plasmodium falciparum in children |
| Q64084567 | Development of B Cell Memory in Malaria |
| Q35903025 | Developmental allometry and paediatric malaria |
| Q34066910 | Differential requirement for cathepsin D for processing of the full length and C-terminal fragment of the malaria antigen MSP1. |
| Q36539692 | Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific |
| Q34478989 | Dynamics of malaria transmission and susceptibility to clinical malaria episodes following treatment of Plasmodium falciparum asymptomatic carriers: results of a cluster-randomized study of community-wide screening and treatment, and a parallel ento |
| Q39589730 | Dynamics of the antibody response to Plasmodium falciparum infection in African children |
| Q33385010 | Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses. |
| Q31043964 | Estimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models |
| Q34209043 | Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens |
| Q46222698 | Evaluating anti-disease immunity to malaria and implications for vaccine design. |
| Q33654911 | Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development |
| Q90665758 | Fast and fierce versus slow and smooth: Heterogeneity in immune responses to Plasmodium in the controlled human malaria infection model |
| Q33518486 | Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice |
| Q36593933 | Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection |
| Q49220322 | High Level of Specific Anti-Plasmodium Falciparum Merozoite IgG1 Antibodies in Rural Asymptomatic Individuals of Dienga, South-Eastern Gabon |
| Q37411770 | High and Heterogeneous Prevalence of Asymptomatic and Sub-microscopic Malaria Infections on Islands in Lake Victoria, Kenya |
| Q34965654 | High antibody responses against Plasmodium falciparum in immigrants after extended periods of interrupted exposure to malaria |
| Q60044485 | Host genetic polymorphisms and serological response against malaria in a selected population in Sri Lanka |
| Q50062994 | Identifying Immune Correlates of Protection Against Plasmodium falciparum Through a Novel Approach to Account for Heterogeneity in Malaria Exposure |
| Q33584320 | IgG isotypic antibodies to crude Plasmodium falciparum blood-stage antigen associated with placental malaria infection in parturient Cameroonian women |
| Q38689264 | Immunity to malaria in an era of declining malaria transmission |
| Q37194482 | Immunity to malaria: more questions than answers |
| Q89559305 | Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial |
| Q38938701 | Immunogenicity of glycosylphosphatidylinositol-anchored micronemal antigen in natural Plasmodium vivax exposure |
| Q38690037 | Immunological processes underlying the slow acquisition of humoral immunity to malaria |
| Q35547272 | Impact of acute malaria on pre-existing antibodies to viral and vaccine antigens in mice and humans |
| Q90243753 | Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers |
| Q38865826 | Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda |
| Q36968260 | Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations |
| Q37770828 | Interferon-γ--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria |
| Q35689469 | Kinetics of humoral and memory B cell response induced by the Plasmodium falciparum 19-kilodalton merozoite surface protein 1 in mice |
| Q40592413 | Longevity of Genotype-Specific Immune Responses to Plasmodium falciparum Merozoite Surface Protein 1 in Kenyan Children from Regions of Different Malaria Transmission Intensity |
| Q35678578 | Malaria and immunity during pregnancy and postpartum: a tale of two species |
| Q36796894 | Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast |
| Q33821137 | Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease |
| Q35649750 | Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function |
| Q34552879 | Measurement of Plasmodium falciparum transmission intensity using serological cohort data from Indonesian schoolchildren |
| Q47396685 | Mechanisms of naturally acquired immunity to P. falciparum and approaches to identify merozoite antigen targets |
| Q37129892 | Merozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity |
| Q90009659 | Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination |
| Q90595442 | Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic Antigens |
| Q35216634 | New antigens for a multicomponent blood-stage malaria vaccine |
| Q36330969 | New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women |
| Q36094704 | Novel flow cytometry technique for detection of Plasmodium falciparum specific B-cells in humans: increased levels of specific B-cells in ongoing infection |
| Q35961275 | Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities |
| Q31139546 | Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria |
| Q57055717 | Osmolytes in vaccine production, flocculation and storage: a critical review |
| Q35532952 | Parasite Specific Antibody Increase Induced by an Episode of Acute P. falciparum Uncomplicated Malaria |
| Q33319552 | Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children |
| Q35867604 | Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory |
| Q35094826 | Protection of Malian children from clinical malaria is associated with recognition of multiple antigens |
| Q37473432 | Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine |
| Q34653470 | Relationship between malaria incidence and IgG levels to Plasmodium falciparum merozoite antigens in Malian children: impact of hemoglobins S and C. |
| Q34500035 | Research priorities for the development and implementation of serological tools for malaria surveillance |
| Q36417089 | Sample size and power calculations for detecting changes in malaria transmission using antibody seroconversion rate |
| Q35998522 | Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia |
| Q37394822 | Serological markers to measure recent changes in malaria at population level in Cambodia |
| Q110697512 | Serology for Plasmodium vivax surveillance: A novel approach to accelerate towards elimination |
| Q36539299 | Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens |
| Q35861487 | Suppression of circulating IgD+CD27+ memory B cells in infants living in a malaria-endemic region of Kenya |
| Q64990601 | TH1-Polarized TFH Cells Delay Naturally-Acquired Immunity to Malaria. |
| Q36728063 | Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children |
| Q37285846 | Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults |
| Q33587496 | The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections |
| Q34047037 | The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission |
| Q29030212 | The contribution of Plasmodium chabaudi to our understanding of malaria |
| Q38127456 | The design and statistical power of treatment re-infection studies of the association between pre-erythrocytic immunity and infection with Plasmodium falciparum |
| Q28744581 | The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania |
| Q35217416 | The effect of daily co-trimoxazole prophylaxis on natural development of antibody-mediated immunity against P. falciparum malaria infection in HIV-exposed uninfected Malawian children |
| Q36142172 | The effect of declining exposure on T cell-mediated immunity to Plasmodium falciparum - an epidemiological "natural experiment". |
| Q33982957 | Toward a surrogate marker of malaria exposure: modeling longitudinal antibody measurements under outbreak conditions |
| Q28554673 | Type I Interferons Induce T Regulatory 1 Responses and Restrict Humoral Immunity during Experimental Malaria |
| Q33998176 | Using serological measures to monitor changes in malaria transmission in Vanuatu |
| Q46161949 | Variation in the immune responses against Plasmodium falciparum merozoite surface protein-1 and apical membrane antigen-1 in children residing in the different epidemiological strata of malaria in Cameroon |
| Q37413044 | What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity |
| Q37426820 | World Malaria Day 2009: what malaria knows about the immune system that immunologists still do not. |
| Q27687235 | Young lives lost as B cells falter: what we are learning about antibody responses in malaria |
Search more.